424 F.3d 1347 (Fed. Cir. 2005), 04-1581, Novo Nordisk Pharmaceuticals, Inc. v. Bio-Technology General Corp.
Linked as:
Extract
424 F.3d 1347 (Fed. Cir. 2005), 04-1581, Novo Nordisk Pharmaceuticals, Inc. v. Bio-Technology General Corp.
No longer available (Autolink)
See the full content of this document
This document cites
- US Code - 35 U.S.C. § 102 Conditions For Patentability; Novelty
- US Code - 35 U.S.C. § 103 Conditions For Patentability; Non-Obvious Subject Matter
- US Code - 35 U.S.C. § 112 Specification
- US Code - 35 U.S.C. § 146 Civil Action In Case of Derivation Proceeding
- Code of Federal Regulations - Duty to disclose information material to patentability